Research Advances Offer Optimism for the Future of Brain Tumor Treatments

Executive Vice President for Health Affairs and Dean of the Duke University School of Medicine Mary Klotman talks with David M. Ashley, Director of the Preston Robert Tisch Brain Tumor Center at Duke.

In an interview with School of Medicine Dean Dr. Mary Klotman, Dr. David Ashley explains some of the challenges of treating brain tumors and the exciting advancements his team is pursuing, including the recent FDA approval of a drug for low-grade gliomas. Ashley, director of the brain tumor center, outlines the team’s interdisciplinary approach to developing the treatment and administering it here at Duke.